Smoking's Impact on Gouty Arthritis
Smoking should be discouraged in patients with gout as it is detrimental to overall health outcomes, despite potentially having a paradoxical effect on serum uric acid levels. 1
Relationship Between Smoking and Gout
Smoking has a complex relationship with gouty arthritis:
Paradoxical Effect: While some research suggests smoking may be associated with lower serum uric acid levels, this does not translate to clinical benefit for gout patients 2, 3
EULAR Guidelines: The European League Against Rheumatism (EULAR) explicitly recommends that smoking should be addressed as an important part of gout management, with a strong recommendation strength of 91% (95% CI, 86 to 97) 1
Overall Health Impact: Smoking negatively impacts many health outcomes in people with rheumatic and musculoskeletal diseases (RMDs), including:
- Increased disease activity
- Decreased function
- Accelerated disease progression
- Higher risk of comorbidities 1
Percentage Contribution and Mechanisms
The exact percentage contribution of smoking to gouty arthritis is not definitively established in the current literature. However, several mechanisms have been proposed:
Comorbidity Association: Smoking strongly associates with alcohol consumption, which is a well-established risk factor for gout flares 1
Medication Response: Smoking may limit response to disease-modifying anti-rheumatic drugs (DMARDs) in rheumatic conditions 1
Cardiovascular Risk: Smoking increases the risk of cardiovascular disease, which is already elevated in gout patients due to metabolic syndrome 1
Clinical Recommendations
Smoking Cessation: All patients with gout should be encouraged to stop smoking and informed about its detrimental effects on overall health outcomes 1
Alcohol Moderation: Since smoking often associates with alcohol consumption, addressing both behaviors is important as moderate alcohol consumption (particularly beer and spirits) increases risk of gout flares 1, 4
Comorbidity Management: Address associated conditions such as hyperlipidemia, hypertension, hyperglycemia, and obesity as part of comprehensive gout management 1
Support for Quitting: Provide support for smoking cessation and monitor progress toward quitting 1
Important Caveats
Conflicting Evidence: Meta-analyses show inconsistent results regarding smoking and gout risk, with some suggesting no association (random effects model) and others suggesting a potential protective effect (fixed effects model) 5
Rapid Loss of Effect: Any potential "protective" effect of smoking on serum urate levels appears to be rapidly lost after smoking cessation 2
Gender Differences: Some studies suggest the relationship between smoking and gout risk may differ between men and women 2
Risk-Benefit Consideration: Even if smoking might have some paradoxical effect on uric acid levels, the overall negative health impacts far outweigh any potential benefit 1
Clinicians should emphasize that despite some contradictory evidence about smoking's relationship with serum urate levels, the overall harmful effects of smoking on general health and rheumatic disease outcomes make smoking cessation an essential component of gout management.